Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (221-230 of 364) with videos related to

Pageof 37
Sort By:
HIV Medicine|April 24, 2023
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIVCatherine Isitt, Angela Bartolf, Nick Andrews, et al.
Infection and Immunity|September 23, 2003
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdomRay Borrow, David Goldblatt, Adam Finn, et al.
Journal of Neurosurgery|October 1, 2014
Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injuryRebekah Mannix, Jacqueline Berglass, Justin Berkner, et al.
Clinical and Vaccine Immunology : CVI|December 31, 2010
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of ageElizabeth Miller, Nick Andrews, Pauline Waight, et al.
BMC Medicine|June 8, 2021
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infantsChristine Elizabeth Jones, Anna Calvert, Jo Southern, et al.
Vaccine|March 2, 2025
Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandMatt J Keeling, Edward M Hill, Stavros Petrou, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlersDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
The Journal of Infection|January 27, 2022
Disease severity during SARS-COV-2 reinfection: a nationwide studyAnna A Mensah, Joanne Lacy, Julia Stowe, et al.
Pageof 37

Showing results (221-230 of 364) with videos related to

Sort By:
Pageof 37
HIV Medicine|April 24, 2023
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIVCatherine Isitt, Angela Bartolf, Nick Andrews, et al.
Infection and Immunity|September 23, 2003
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdomRay Borrow, David Goldblatt, Adam Finn, et al.
Journal of Neurosurgery|October 1, 2014
Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injuryRebekah Mannix, Jacqueline Berglass, Justin Berkner, et al.
Clinical and Vaccine Immunology : CVI|December 31, 2010
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of ageElizabeth Miller, Nick Andrews, Pauline Waight, et al.
BMC Medicine|June 8, 2021
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infantsChristine Elizabeth Jones, Anna Calvert, Jo Southern, et al.
Vaccine|March 2, 2025
Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandMatt J Keeling, Edward M Hill, Stavros Petrou, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlersDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
The Journal of Infection|January 27, 2022
Disease severity during SARS-COV-2 reinfection: a nationwide studyAnna A Mensah, Joanne Lacy, Julia Stowe, et al.
Pageof 37